DeepSynapsCLINICAL INTELLIGENCE OS
Research overview

Brain stimulation for depression: the research on rTMS, tDCS, VNS and PBM compared

Four neuromodulation approaches to depression have their own DeepSynaps evidence map: rTMS for major depressive disorder, tDCS for depression, VNS for treatment-resistant depression, PBM for major depressive disorder. This article compares how much research exists for each: papers, randomised trials, reviews and growth over time (snapshot 2026-09-25).

DeepSynaps · · data snapshot 2026-09-25

Papers, trials and reviews

Treatment and conditionPapersRCTsMeta-analysesSystematic reviewsRCT share
rTMS for major depressive disorder3,32071327214121.5%
tDCS for depression1,2323441138427.9%
VNS for treatment-resistant depression1,0439124328.7%
PBM for major depressive disorder129272520.9%

RCT share is the proportion of a map's papers labelled as randomised controlled trials.

How the research has grown

The most-cited trial on each map

Citation counts measure attention in the literature, not the size or quality of an effect.

How to read these numbers

Each map counts papers tagged to that treatment and condition in the curated DeepSynaps v6 corpus; papers Jev confidently judged off-topic are excluded. Counts describe how much has been published, not how well the treatment works.

Study designs are AI-classified by Jev: advisory, not clinician-reviewed. Some papers on each map have no confident study-design label yet, so the trial and review columns are lower bounds.

Totals include papers from 2026, which was still in progress at the snapshot (2026-09-25). The growth comparison uses complete years only.

Decision support only. This article summarises published literature; it is not medical advice or a recommendation for any patient. Data snapshot 2026-09-25.